Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein - Concepedia

Concepedia

Publication | Closed Access

Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein

290

Citations

16

References

2010

Year

Wolfgang Glaesner, Andrew Vick, Rohn Millican, Bernice Ellis, Sheng‐Hung Tschang, Yu Tian, Krister Bokvist, Martin Brenner, Anja Köester, Niels Pörksen,

Diabetes/Metabolism Research and Reviews

Abstract

LY2189265 retains the effects of GLP-1 with increased half-life and efficacy, supporting further evaluation as a once-weekly treatment of type 2 diabetes.

References

	Year	Citations

Page 1